Literature DB >> 27902824

Trends in Total Cholesterol, Triglycerides, and Low-Density Lipoprotein in US Adults, 1999-2014.

Asher Rosinger1, Margaret D Carroll2, David Lacher2, Cynthia Ogden2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27902824      PMCID： PMC7388068          DOI： 10.1001/jamacardio.2016.4396

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


× No keyword cloud information.
  5 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Levels of plasma trans-fatty acids in non-Hispanic white adults in the United States in 2000 and 2009.

Authors:  Hubert W Vesper; Heather C Kuiper; Lisa B Mirel; Clifford L Johnson; James L Pirkle
Journal:  JAMA       Date:  2012-02-08       Impact factor: 56.272

Review 3.  Triglycerides on the rise: should we swap seats on the seesaw?

Authors:  Peter Libby
Journal:  Eur Heart J       Date:  2014-12-29       Impact factor: 29.983

4.  Trends in lipids and lipoproteins in US adults, 1988-2010.

Authors:  Margaret D Carroll; Brian K Kit; David A Lacher; Susan T Shero; Michael E Mussolino
Journal:  JAMA       Date:  2012-10-17       Impact factor: 56.272

5.  Temporal Trends in Mortality in the United States, 1969-2013.

Authors:  Jiemin Ma; Elizabeth M Ward; Rebecca L Siegel; Ahmedin Jemal
Journal:  JAMA       Date:  2015-10-27       Impact factor: 56.272
  5 in total
  11 in total

1.  Trends in Apolipoprotein B, Non-High-Density Lipoprotein, and Low-Density Lipoprotein for Adults 60 Years and Older by Use of Lipid-Lowering Medications: United States, 2005 to 2006 Through 2013 to 2014.

Authors:  Margaret D Carroll; Michael E Mussolino; Michael Wolz; Pothur R Srinivas
Journal:  Circulation       Date:  2018-07-10       Impact factor: 29.690

2.  Trends in Lipid Concentrations and Lipid Control Among US Adults, 2007-2018.

Authors:  Rahul Aggarwal; Deepak L Bhatt; Fatima Rodriguez; Robert W Yeh; Rishi K Wadhera
Journal:  JAMA       Date:  2022-08-23       Impact factor: 157.335

3.  Mathematical modelling of the most effective goal of cholesterol-lowering treatment in primary prevention.

Authors:  Handrean Soran; Safwaan Adam; Zohaib Iqbal; Paul Durrington
Journal:  BMJ Open       Date:  2022-05-24       Impact factor: 3.006

4.  Residual Risk of Atherosclerotic Cardiovascular Events in Relation to Reductions in Very-Low-Density Lipoproteins.

Authors:  Patrick R Lawler; Akintunde O Akinkuolie; Paulo Harada; Robert J Glynn; Daniel I Chasman; Paul M Ridker; Samia Mora
Journal:  J Am Heart Assoc       Date:  2017-12-09       Impact factor: 5.501

5.  Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol.

Authors:  Patrick R Lawler; Akintunde O Akinkuolie; Audrey Y Chu; Svati H Shah; William E Kraus; Damian Craig; Latha Padmanabhan; Robert J Glynn; Paul M Ridker; Daniel I Chasman; Samia Mora
Journal:  J Am Heart Assoc       Date:  2017-07-21       Impact factor: 5.501

Review 6.  Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics.

Authors:  William E Boden; Deepak L Bhatt; Peter P Toth; Kausik K Ray; M John Chapman; Thomas F Lüscher
Journal:  Eur Heart J       Date:  2020-06-21       Impact factor: 29.983

7.  Trends in Comorbid Conditions Among Medicaid Enrollees With HIV.

Authors:  Megan B Cole; Omar Galárraga; Momotazur Rahman; Ira B Wilson
Journal:  Open Forum Infect Dis       Date:  2019-03-10       Impact factor: 3.835

8.  Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI.

Authors:  Benjamin E Peterson; Deepak L Bhatt; Ph Gabriel Steg; Michael Miller; Eliot A Brinton; Terry A Jacobson; Steven B Ketchum; Rebecca A Juliano; Lixia Jiao; Ralph T Doyle; Craig Granowitz; C Michael Gibson; Duane Pinto; Robert P Giugliano; Matthew J Budoff; Jean-Claude Tardif; Subodh Verma; Christie M Ballantyne
Journal:  J Am Heart Assoc       Date:  2022-03-09       Impact factor: 6.106

9.  US life expectancy stalls due to cardiovascular disease, not drug deaths.

Authors:  Neil K Mehta; Leah R Abrams; Mikko Myrskylä
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-16       Impact factor: 11.205

Review 10.  Health disparities in cardiometabolic risk among Black and Hispanic youth in the United States.

Authors:  Sophia Figueroa Katz; Fatima Rodriguez; Joshua W Knowles
Journal:  Am J Prev Cardiol       Date:  2021-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.